Article
Retroviral transfer of acid alpha-glucosidase cDNA to enzyme-deficient myoblasts results in phenotypic spread of the genotypic correction by both secretion and fusion.
Human gene therapy - 1 Sept 1997
Zaretsky J Z, Candotti F, Boerkoel C, Adams E M, Yewdell J W, Blaese R M, Plotz P H
Abstract excerpt
Myoblasts have properties that make them suitable vehicles for gene replacement therapy, and lysosomal storage diseases are attractive targets for such therapy. Type II Glycogen Storage Disease, a deficiency of acid alpha-glucosidase (GAA), results in the abnormal accumulation of glycogen in skeletal and cardiac muscle lysosomes. The varied manifestations of the enzyme deficiency in affected patient are...
Topics
- Cell Fusion
- DNA, Complementary
- Gene Transfer Techniques
- Genetic Therapy
- Genotype
- Glucan 1,4-alpha-Glucosidase
- Glycogen Storage Disease Type II
- Humans
- Microscopy, Electron
- Muscles